PRICE T ROWE ASSOCIATES INC /MD/ - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$25,094,000
-15.8%
911,191
-49.6%
0.00%
-33.3%
Q1 2021$29,788,000
-17.9%
1,806,445
-8.3%
0.00%
-25.0%
Q4 2020$36,287,000
+45.7%
1,968,931
+7.6%
0.00%
+33.3%
Q3 2020$24,897,000
-28.5%
1,829,295
-5.8%
0.00%
-25.0%
Q2 2020$34,807,000
+2122.7%
1,942,373
+1136.7%
0.00%
Q1 2020$1,566,000
+13.0%
157,064
-7.7%
0.00%
Q4 2019$1,386,000170,2090.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders